EVENTS

2023/01/01
230101謹賀新年三重大学海岸より

2022/11/18
日本患者由来がんモデル学会学術集会２０２２

2022/10/05
三重大学システムズ薬理学セミナー

2022/07/02
High-Content Functional Screening for Oncocardiology Using Novel Translucent Cardiac Fluorescent Protein Transgenic Zebrafishes

2021/12/23
募集期間は、あと３７時間となりました。

一覧へ

》Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening

                     
2021/10/13

BioJapan2021: Oct 13-15, 2021
We developed novel zebrafish model for patient-derived xenograft (PDXZ), and demonstrated that PDXZ has high rate and speed of engraftment in normal zebrafish when the immune system is immature, requires less than 100 cancer cells for transplantation, and can be quantitatively analyzed in 2 days. We report on drug efficacy screening system that can be quantitatively analyzed within a week.

関連リンク

三重大学大学院医学系研究科システムズ薬理学

biojapan2021

関連ファイル

Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening